Meet the team behind c4c! We are a diverse group of people from many different backgrounds, all working towards a common goal: better medicines for children through European clinical trials. Today’s spotlight is on Ricardo Fernandes, from the University of Lisbon and AIDFM.
Defining how meaningful Patient and Public Involvement (PPI) is realised in practice, (especially where child and young patients are concerned) is limited partly due to the low-level reporting of the processes and outputs of PPI activities in general.
Dear Partners and Friends of conect4children,
At the end of a year which brought a lot of change and uncertainty to the world around us, we would like to reflect on c4c´s achievements of the past year and to look forward to what lies ahead in the coming months.
Patent ductus arteriosus (PDA) in preterm infants is associated with increased morbidities and mortality. Prophylactic treatment with cyclooxygenase inhibitors, as indomethacin or ibuprofen, failed to demonstrate significant clinical benefits. Acetaminophen may represent an alternative treatment option. To read full article, click here